BACKGROUND: Metabolic syndrome and its risk factors are predictors of cardiovascular events. Metabolic syndrome is also directly associated with echocardiographic phenotypes. METHODS: The current study is the first to investigate the factors associated with both metabolic syndrome risk factors and echocardiographic phenotypes and assess their heritability. Multivariate factor analysis was performed on 15 traits in 1393 African-Americans and 1133 whites, as well as stratified by type 2 diabetes mellitus status. RESULTS: Factor analysis with varimax rotation established four to five latent factors across ethnicities and diabetes mellitus stratifications. Among metabolic syndrome risk factors, blood pressure was the most highly correlated with cardiac traits. The factor domains, in the order of the proportion of variance explained, were 'left ventricle wall thickness', 'left ventricle geometry', 'blood pressure', 'BMI-insulin', and 'lipid-insulin'. Factor analysis without any rotation identified special (cross domain) metabolic syndrome-echocardiographic factors, 'blood pressure-left ventricle geometry' and 'blood pressure-left ventricle dimension-wall thickness' in whites. Fifty to 57% of the total original risk factor variance was explained by the latent factors. Heritability was highest for BMI-insulin (37-53%), lowest for 'blood pressure' factors (15-27%), and intermediate for metabolic syndrome-echocardiographic factors. CONCLUSION: These latent factors identified can be utilized as summary phenotypes in epidemiological, linkage, and association studies.
BACKGROUND:Metabolic syndrome and its risk factors are predictors of cardiovascular events. Metabolic syndrome is also directly associated with echocardiographic phenotypes. METHODS: The current study is the first to investigate the factors associated with both metabolic syndrome risk factors and echocardiographic phenotypes and assess their heritability. Multivariate factor analysis was performed on 15 traits in 1393 African-Americans and 1133 whites, as well as stratified by type 2 diabetes mellitus status. RESULTS: Factor analysis with varimax rotation established four to five latent factors across ethnicities and diabetes mellitus stratifications. Among metabolic syndrome risk factors, blood pressure was the most highly correlated with cardiac traits. The factor domains, in the order of the proportion of variance explained, were 'left ventricle wall thickness', 'left ventricle geometry', 'blood pressure', 'BMI-insulin', and 'lipid-insulin'. Factor analysis without any rotation identified special (cross domain) metabolic syndrome-echocardiographic factors, 'blood pressure-left ventricle geometry' and 'blood pressure-left ventricle dimension-wall thickness' in whites. Fifty to 57% of the total original risk factor variance was explained by the latent factors. Heritability was highest for BMI-insulin (37-53%), lowest for 'blood pressure' factors (15-27%), and intermediate for metabolic syndrome-echocardiographic factors. CONCLUSION: These latent factors identified can be utilized as summary phenotypes in epidemiological, linkage, and association studies.
Authors: Richard B Devereux; Giovanni de Simone; Vittorio Palmieri; Albert Oberman; Paul Hopkins; Dalane W Kitzman; Dabeeru C Rao; Donna K Arnett Journal: Am J Hypertens Date: 2002-12 Impact factor: 2.689
Authors: C Cuspidi; L Lonati; G Macca; L Sampieri; V Fusi; I Michev; B Severgnini; M Salerno; F Magrini; A Zanchetti Journal: Blood Press Date: 2001 Impact factor: 2.835
Authors: Isabel Ferreira; Ronald M A Henry; Jos W R Twisk; Willem van Mechelen; Han C G Kemper; Coen D A Stehouwer Journal: Arch Intern Med Date: 2005-04-25
Authors: Cecil M Burchfiel; Thomas N Skelton; Michael E Andrew; Robert J Garrison; Donna K Arnett; Daniel W Jones; Herman A Taylor Journal: Circulation Date: 2005-08-01 Impact factor: 29.690
Authors: Sudhir Kurl; Jari A Laukkanen; Leo Niskanen; David Laaksonen; Juhani Sivenius; Kristiina Nyyssönen; Jukka T Salonen Journal: Stroke Date: 2006-02-09 Impact factor: 7.914
Authors: G de Simone; D K Arnett; M Chinali; M De Marco; D C Rao; A T Kraja; S C Hunt; R B Devereux Journal: Nutr Metab Cardiovasc Dis Date: 2011-05-12 Impact factor: 4.222
Authors: Lisa de las Fuentes; Giovanni de Simone; Donna K Arnett; Víctor G Dávila-Román Journal: Endocr Metab Immune Disord Drug Targets Date: 2010-06 Impact factor: 2.895
Authors: Amy M Matteini; M Daniele Fallin; Candace M Kammerer; Nicole Schupf; Anatoli I Yashin; Kaare Christensen; Konstantin G Arbeev; Graham Barr; Richard Mayeux; Anne B Newman; Jeremy D Walston Journal: J Gerontol A Biol Sci Med Sci Date: 2010-09-02 Impact factor: 6.053
Authors: Keri L Monda; Kari E North; Steven C Hunt; D C Rao; Michael A Province; Aldi T Kraja Journal: Endocr Metab Immune Disord Drug Targets Date: 2010-06 Impact factor: 2.895
Authors: Aldi T Kraja; Pinchia Huang; Weihong Tang; Steven C Hunt; Kari E North; Cora E Lewis; Richard B Devereux; Giovanni de Simone; Donna K Arnett; Treva Rice; D C Rao Journal: BMC Med Genet Date: 2008-11-27 Impact factor: 2.103